Does GLICLAZIDE Cause Pulmonary hypertension? 36 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 36 reports of Pulmonary hypertension have been filed in association with GLICLAZIDE. This represents 0.6% of all adverse event reports for GLICLAZIDE.
36
Reports of Pulmonary hypertension with GLICLAZIDE
0.6%
of all GLICLAZIDE reports
15
Deaths
35
Hospitalizations
How Dangerous Is Pulmonary hypertension From GLICLAZIDE?
Of the 36 reports, 15 (41.7%) resulted in death, 35 (97.2%) required hospitalization, and 6 (16.7%) were considered life-threatening.
Is Pulmonary hypertension Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLICLAZIDE. However, 36 reports have been filed with the FAERS database.
What Other Side Effects Does GLICLAZIDE Cause?
Hypoglycaemia (756)
Nausea (596)
Acute kidney injury (553)
Drug ineffective (507)
Fall (415)
Dyspnoea (400)
Vomiting (385)
Lactic acidosis (373)
Malaise (360)
Hypertension (351)
What Other Drugs Cause Pulmonary hypertension?
TREPROSTINIL (1,931)
MACITENTAN (1,505)
AMBRISENTAN (1,504)
SELEXIPAG (681)
EPOPROSTENOL (591)
SILDENAFIL (517)
BOSENTAN (504)
TADALAFIL (428)
RIOCIGUAT (411)
ADALIMUMAB (287)
Which GLICLAZIDE Alternatives Have Lower Pulmonary hypertension Risk?
GLICLAZIDE vs GLIMEPIRIDE
GLICLAZIDE vs GLIMEPIRIDE\ROSIGLITAZONE
GLICLAZIDE vs GLIPIZIDE
GLICLAZIDE vs GLIVEC
GLICLAZIDE vs GLOFITAMAB